Molecular requirements for epithelial-mesenchymal transition during tumor progression

Current Opinion in Cell Biology

Volumn 17, Issue 5 SPEC. ISS., 2005, Pages 548-558

  Huber, Margit A ^a,b   Kraut, Norbert ^c   Beug, Hartmut ^b  

^a Universitatsklinik fur Dermatologie   (Austria)

^b RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^c BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CATENIN; ERLOTINIB; GEFITINIB; GLYCOGEN SYNTHASE KINASE 3BETA; IMATINIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NOTCH RECEPTOR; RAS PROTEIN; SMAD PROTEIN; SONIC HEDGEHOG PROTEIN; STAT3 PROTEIN; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; TRASTUZUMAB; WNT PROTEIN;

APOPTOSIS; AUTOCRINE EFFECT; CANCER CELL CULTURE; CANCER GROWTH; CELL MATURATION; EPITHELIUM CELL; GENE FUNCTION; GENE REPRESSION; MESENCHYME; MOLECULAR RECOGNITION; NONHUMAN; ONCOGENE RAS; PHASE TRANSITION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN SYNTHESIS REGULATION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

ERINACEIDAE; GASTROPODA;

EID: 24644480749     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2005.08.001     Document Type: Review

References (73)

1. J.P. Thiery Epithelial-mesenchymal transitions in tumour progression Nat Rev Cancer 2 2002 442 454
2. J.P. Thiery Epithelial-mesenchymal transitions in development and pathologies Curr Opin Cell Biol 15 2003 740 746
3. S. Grünert, M. Jechlinger, and H. Beug Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis Nat Rev Mol Cell Biol 4 2003 657 665
4. R. Kalluri, and E.G. Neilson Epithelial-mesenchymal transition and its implications for fibrosis J Clin Invest 112 2003 1776 1784
5. A. Nawshad, D. LaGamba, and E.D. Hay Transforming growth factor β (TGFβ) signalling in palatal growth, apoptosis and epithelial mesenchymal transformation (EMT) Arch Oral Biol 49 2004 675 689
6. F. Balkwill Cancer and the chemokine network Nat Rev Cancer 4 2004 540 550
7. Eger A, Mikulits W: Models of epithelial-mesenchymal transition. Drug Discovery Today: Disease Models. 2005, in press.
8. J. Gotzmann, M. Mikula, A. Eger, R. Schulte-Hermann, R. Foisner, H. Beug, and W. Mikulits Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis Mutat Res 566 2004 9 20
9. J.M. Yingling, K.L. Blanchard, and J.S. Sawyer Development of TGF-β signalling inhibitors for cancer therapy Nat Rev Drug Discov 3 2004 1011 1022
10. D. Bilder Epithelial polarity and proliferation control: links from the Drosophila neoplastic tumor suppressors Genes Dev 18 2004 1909 1925
11. A. Besson, R.K. Assoian, and J.M. Roberts Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors? Nat Rev Cancer 4 2004 948 955
12. M.M. Mueller, and N.E. Fusenig Friends or foes - bipolar effects of the tumour stroma in cancer Nat Rev Cancer 4 2004 839 849
13. L. Xie, B.K. Law, A.M. Chytil, K.A. Brown, M.E. Aakre, and H.L. Moses Activation of the Erk pathway is required for TGF-β1-induced EMT in vitro Neoplasia 6 2004 603 610
14. S.E. Seton-Rogers, Y. Lu, L.M. Hines, M. Koundinya, J. LaBaer, S.K. Muthuswamy, and J.S. Brugge Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells Proc Natl Acad Sci USA 101 2004 1257 1262
15. Y. Ueda, S. Wang, N. Dumont, J.Y. Yi, Y. Koh, and C.L. Arteaga Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility J Biol Chem 279 2004 24505 24513
16. P.M. Siegel, W. Shu, R.D. Cardiff, W.J. Muller, and J. Massague Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis Proc Natl Acad Sci USA 100 2003 8430 8435
17. L. Lamorte, I. Royal, M. Naujokas, and M. Park Crk adapter proteins promote an epithelial-mesenchymal-like transition and are required for HGF-mediated cell spreading and breakdown of epithelial adherens junctions Mol Biol Cell 13 2002 1449 1461
18. A. Eger, A. Stockinger, J. Park, E. Langkopf, M. Mikula, J. Gotzmann, W. Mikulits, H. Beug, and R. Foisner β-Catenin and TGFβ signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition Oncogene 23 2004 2672 2680
19. A. Schulze, B. Nicke, P.H. Warne, S. Tomlinson, and J. Downward The transcriptional response to Raf activation is almost completely dependent on mitogen-activated protein kinase kinase activity and shows a major autocrine component Mol Biol Cell 15 2004 3450 3463
20. M.N. Pollak, E.S. Schernhammer, and S.E. Hankinson Insulin-like growth factors and neoplasia Nat Rev Cancer 4 2004 505 518
21. M. Jechlinger, S. Grunert, I.H. Tamir, E. Janda, S. Ludemann, T. Waerner, P. Seither, A. Weith, H. Beug, and N. Kraut Expression profiling of epithelial plasticity in tumor progression Oncogene 22 2003 7155 7169 An expression profiling study of seven closely related cell pairs, using fully polarized mammary epithelial cells, modified by defined oncogenes and/or external factors and representing specific aspects of epithelial plasticity changes: EMT, metastasis, scattering and/or oncogene function. The study describes a small set of genes specifically regulated during EMT, including known EMT inducers/repressors as well as potential novel regulators.
22. W.J. Nelson, and R. Nusse Convergence of Wnt, β-catenin, and cadherin pathways Science 303 2004 1483 1487
23. S. Liebner, A. Cattelino, R. Gallini, N. Rudini, M. Iurlaro, S. Piccolo, and E. Dejana β-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse J Cell Biol 166 2004 359 367
24. F. Radtke, and K. Raj The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer 3 2003 756 767
25. L.A. Timmerman, J. Grego-Bessa, A. Raya, E. Bertran, J.M. Perez-Pomares, J. Diez, S. Aranda, S. Palomo, F. McCormick, and J.C. Izpisua-Belmonte Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation Genes Dev 18 2004 99 115
26. J. Zavadil, L. Cermak, N. Soto-Nieves, and E.P. Bottinger Integration of TGF-β/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition EMBO J 23 2004 1155 1165 A convincing study showing the requirement for Notch signaling in TGFβ-induced EMT in established and primary epithelial cells. A downstream effector of Notch (Hey1, an E-cadherin repressor) is co-induced by both Jagged-induced Notch- and TGFβ-Smad3-dependent signaling during TGFβ-induced EMT, and a joint functional role for Smad3, Hey1 and Jagged-1 during TGFβ-induced EMT is established. Together with complementary data from Timmerman et al. [25] showing that EMT is dependent on upregulation of Snail by TGFβ via Notch signaling in heart development and endothelial cell transformation, this establishes that Notch signaling plays an important role in EMT.
27. J. Grego-Bessa, J. Diez, L. Timmerman, and J.L. de la Pompa Notch and epithelial-mesenchyme transition in development and tumor progression: another turn of the screw Cell Cycle 3 2004 718 721
28. M. Pasca di Magliano, and M. Hebrok Hedgehog signalling in cancer formation and maintenance Nat Rev Cancer 3 2003 903 911
29. S.S. Karhadkar, G.S. Bova, N. Abdallah, S. Dhara, D. Gardner, A. Maitra, J.T. Isaacs, D.M. Berman, and P.A. Beachy Hedgehog signalling in prostate regeneration, neoplasia and metastasis Nature 431 2004 707 712 An elegant demonstration of the role of Hedgehog signaling in causing EMT and metastasis in prostate cancer. Elevated Hedgehog signaling is involved in both prostate regeneration through tissue stem cells and the metastatic ability of prostate cancers; the latter process is shown to involve metastasis-specific upregulation of the signal transducer Smoothened (Smo). Using overexpression and pathway inhibition by the specific small molecule inhibitor cyclopamine, Gli-1, a downstream effector of the Hedgehog pathway, is shown to cause enhanced migration in vitro, enhanced Snail expression and metastasis in non-metastatic rodent prostate cancer cell lines.
30. I.D. Louro, E.C. Bailey, X. Li, L.S. South, P.R. McKie-Bell, B.K. Yoder, C.C. Huang, M.R. Johnson, A.E. Hill, and R.L. Johnson Comparative gene expression profile analysis of GLI and c-MYC in an epithelial model of malignant transformation Cancer Res 62 2002 5867 5873
31. J.L. Mullor, N. Dahmane, T. Sun, and A. Ruiz i Altaba Wnt signals are targets and mediators of Gli function Curr Biol 11 2001 769 773
32. U. Cavallaro, and G. Christofori Cell adhesion and signalling by cadherins and Ig-CAMs in cancer Nat Rev Cancer 4 2004 118 132
33. H. Peinado, F. Portillo, and A. Cano Transcriptional regulation of cadherins during development and carcinogenesis Int J Dev Biol 48 2004 365 375
34. M.A. Nieto The snail superfamily of zinc-finger transcription factors Nat Rev Mol Cell Biol 3 2002 155 166
35. A. Eger, K. Aigner, S. Sonderegger, B. Dampier, S. Oehler, M. Schreiber, G. Berx, A. Cano, H. Beug, and R. Foisner δEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells Oncogene 24 2005 2375 2385 This paper shows that the snail family member δEF1/ZEB-1 is upregulated during EMT in a cell culture tumor model and that its ectopic expression in epithelial cells is sufficient to downregulate endogenous E-cadherin, resulting in EMT induction. Furthermore, overexpression as well as knock-down studies show that δEF1/ZEB-1 directly represses E-cadherin in human tumor cells.
36. M.A. Perez-Moreno, A. Locascio, I. Rodrigo, G. Dhondt, F. Portillo, M.A. Nieto, and A. Cano A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions J Biol Chem 276 2001 27424 27431
37. M. Kondo, E. Cubillo, K. Tobiume, T. Shirakihara, N. Fukuda, H. Suzuki, K. Shimizu, K. Takehara, A. Cano, and M. Saitoh A role for Id in the regulation of TGF-beta-induced epithelial-mesenchymal transdifferentiation Cell Death Differ 11 2004 1092 1101
38. M. Kowanetz, U. Valcourt, R. Bergstrom, C.H. Heldin, and A. Moustakas Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor β and bone morphogenetic protein Mol Cell Biol 24 2004 4241 4254
39. H. Peinado, M. Quintanilla, and A. Cano Transforming growth factor β-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions J Biol Chem 278 2003 21113 21123
40. J. Yang, S.A. Mani, J.L. Donaher, S. Ramaswamy, R.A. Itzykson, C. Come, P. Savagner, I. Gitelman, A. Richardson, and R.A. Weinberg Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis Cell 117 2004 927 939 This study uses microarray technology to exploit a breast cancer metastasis model consisting of four spontaneously arising mouse breast tumor lines with distinctive metastatic properties. The bHLH transcription factor Twist is identified as a gene upregulated early during metastatic progression, and is functionally validated as a critical regulator of metastasis, using short interfering RNAs. Twist is able to promote EMT in mammary epithelial cells, in part via downregulation of E-cadherin. The high levels of Twist expression seen in 70% of invasive lobular breast carcinomas, which display many features of EMT, are inversely correlated with E-cadherin expression. Identification of Twist provides a powerful tool for studying the role of EMT during tumor metastasis, in particular during the movement of cells from a primary tumor into the circulation.
41. Y. Kang, and J. Massague Epithelial-mesenchymal transitions: twist in development and metastasis Cell 118 2004 277 279
42. E. Rosivatz, I. Becker, K. Specht, E. Fricke, B. Luber, R. Busch, H. Hofler, and K.F. Becker Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer Am J Pathol 161 2002 1881 1891
43. S. Vega, A.V. Morales, O.H. Ocana, F. Valdes, I. Fabregat, and M.A. Nieto Snail blocks the cell cycle and confers resistance to cell death Genes Dev 18 2004 1131 1143
44. M.A. Huber, N. Azoitei, B. Baumann, S. Grunert, A. Sommer, H. Pehamberger, N. Kraut, H. Beug, and T. Wirth NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression J Clin Invest 114 2004 569 581 The authors show that NF-κB is essential for EMT in a breast cancer model. Ha-Ras-transformed mammary epithelial cells, which undergo EMT in response to TGFβ, are prevented from progressing through EMT when NF-κB activity is blocked. NF-κB pathway activation, however, promotes EMT even without TGFβ. Moreover, NF-κB inhibition reverses EMT in mesenchymal cells. Inhibiting the NF-κB pathway in mice injected with the Ha-Ras-transformed mammary epithelial cells abrogates the metastatic potential of these cells. Collectively, these data provide evidence that NF-κB plays an essential role in both the induction and maintenance of EMT.
45. R.E. Bachelder, S.O. Yoon, C. Franci, A.G. de Herreros, and A.M. Mercurio Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition J Cell Biol 168 2005 29 33
46. B.P. Zhou, J. Deng, W. Xia, J. Xu, Y.M. Li, M. Gunduz, and M.C. Hung Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial-mesenchymal transition Nat Cell Biol 6 2004 931 940 A thorough biochemical study showing that GSK-3β, which is an important signal intermediate in the Wnt/β-catenin pathway and which is functionally inactivated by PI3K-dependent phosphorylation, regulates both the E-cadherin repressor Snail and EMT. Active GSK-3 induces both ubiquitin-dependent destruction and inactivation by cytoplasmic localization of Snail by phosphorylation at distinct sites. A Snail variant that is non-phosphorylatable at both sites is sufficient to cause EMT, and a correlation is observed between inactive, phosphorylated GSK-3 and Snail expression in human breast carcinomas.
47. H. Yu, and R. Jove The STATS of cancer - new molecular targets come of age Nat Rev Cancer 4 2004 97 105
48. T.J. Yeatman A renaissance for SRC Nat Rev Cancer 4 2004 470 480
49. S. Yamashita, C. Miyagi, T. Fukada, N. Kagara, Y.S. Che, and T. Hirano Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer Nature 429 2004 298 302 An elegant study in zebrafish, providing genetic and biochemical evidence for a novel pathway in developmental EMT during gastrulation. The signal transducer and activator of transcription (STAT)3 is required for gastrulation and causes direct transcriptional activation of LIV-1, a member of the LZT subfamily of transmembrane Zinc transporters. LIV-1 is shown to be a downstream effector of STAT3 that is essential for EMT and to cause nuclear localization and E-cadherin-repressive activity of the EMT effector Snail.
50. K.M. Taylor, and R.I. Nicholson The LZT proteins; the LIV-1 subfamily of zinc transporters Biochim Biophys Acta 1611 2003 16 30
51. N. Fujita, D.L. Jaye, M. Kajita, C. Geigerman, C.S. Moreno, and P.A. Wade MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer Cell 113 2003 207 219 This paper provides an important link between estrogen receptor activity resulting in repression of Snail and expression of E-cadherin in breast carcinoma progression. This work shows a direct repression of Snail transcription by MTA3 in response to estrogen receptor signaling that contributes to maintenance of epithelial integrity in breast cancer.
52. P. Humbert, S. Russell, and H. Richardson Dlg, Scribble and Lgl in cell polarity, cell proliferation and cancer Bioessays 25 2003 542 553
53. R.A. Pagliarini, and T. Xu A genetic screen in Drosophila for metastatic behavior Science 302 2003 1227 1231
54. B. Ozdamar, R. Bose, M. Barrios-Rodiles, H.R. Wang, Y. Zhang, and J.L. Wrana Regulation of the polarity protein Par6 by TGFβ receptors controls epithelial cell plasticity Science 307 2005 1603 1609 The first report in mammalian cells showing that TGFβ signaling and Par6 - a member of a well studied protein complex (Par3, Par6, atypical PKC) that regulates epithelial polarity - cooperate to cause EMT. The TGFβ-receptor subunit I colocalizes with and phosphorylates Par6, an event necessary for TGFβ-induced EMT. In turn, receptor-bound, phosphorylated Par6 recruits and activates the E3-ligase Smurf, which targets the guanine triphosphatase RhoA for proteolytic desctruction, thus abolishing tight junctions.
55. Valcourt U, Kowanetz M, Niimi H, Heldin CH, Moustakas A: TGF-β and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell 2005, in press.
56. Y. Kang, P.M. Siegel, W. Shu, M. Drobnjak, S.M. Kakonen, C. Cordon-Cardo, T.A. Guise, and J. Massague A multigenic program mediating breast cancer metastasis to bone Cancer Cell 3 2003 537 549
57. A.J. Minn, Y. Kang, I. Serganova, G.P. Gupta, D.D. Giri, M. Doubrovin, V. Ponomarev, W.L. Gerald, R. Blasberg, and J. Massague Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors J Clin Invest 115 2005 44 55
58. L.J. van 't Veer, H. Dai, M.J. van de Vijver, Y.D. He, A.A. Hart, M. Mao, H.L. Peterse, K. van der Kooy, M.J. Marton, and A.T. Witteveen Gene expression profiling predicts clinical outcome of breast cancer Nature 415 2002 530 536
59. S. Ramaswamy, K.N. Ross, E.S. Lander, and T.R. Golub A molecular signature of metastasis in primary solid tumors Nat Genet 33 2003 49 54
60. N. Gavert, M. Conacci-Sorrell, D. Gast, A. Schneider, P. Altevogt, T. Brabletz, and A. Ben-Ze'ev L1, a novel target of β-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers J Cell Biol 168 2005 633 642
61. F. Hlubek, S. Spaderna, A. Jung, T. Kirchner, and T. Brabletz β-catenin activates a coordinated expression of the proinvasive factors laminin-5 γ2 chain and MT1-MMP in colorectal carcinomas Int J Cancer 108 2004 321 326
62. O.W. Petersen, H.L. Nielsen, T. Gudjonsson, R. Villadsen, F. Rank, E. Niebuhr, M.J. Bissell, and L. Ronnov-Jessen Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma Am J Pathol 162 2003 391 402
63. K. Pantel, and R.H. Brakenhoff Dissecting the metastatic cascade Nat Rev Cancer 4 2004 448 456
64. J. Condeelis, and J.E. Segall Intravital imaging of cell movement in tumours Nat Rev Cancer 3 2003 921 930
65. A. Gschwind, O.M. Fischer, and A. Ullrich The discovery of receptor tyrosine kinases: targets for cancer therapy Nat Rev Cancer 4 2004 361 370
66. J. Downward Targeting RAS signalling pathways in cancer therapy Nat Rev Cancer 3 2003 11 22
67. M. Karin, Y. Yamamoto, and Q.M. Wang The IKK NF-κB system: a treasure trove for drug development Nat Rev Drug Discov 3 2004 17 26
68. J. Seoane, H.V. Le, L. Shen, S.A. Anderson, and J. Massague Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation Cell 117 2004 211 223
69. A. Oloumi, T. McPhee, and S. Dedhar Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by the integrin-linked kinase Biochim Biophys Acta 1691 2004 1 15
70. Y. Li, J. Yang, C. Dai, C. Wu, and Y. Liu Role for integrin-linked kinase in mediating tubular epithelial-to-mesenchymal transition and renal interstitial fibrogenesis J Clin Invest 112 2003 503 516
71. E.C. Woodhouse, A. Fisher, R.W. Bandle, B. Bryant-Greenwood, L. Charboneau, E.F. Petricoin III, and L.A. Liotta Drosophila screening model for metastasis: Semaphorin 5c is required for l(2)gl cancer phenotype Proc Natl Acad Sci USA 100 2003 11463 11468
72. C.C. Schimanski, G. Schmitz, A. Kashyap, A.K. Bosserhoff, F. Bataille, S.C. Schafer, H.A. Lehr, M.R. Berger, P.R. Galle, and S. Strand Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer Oncogene 24 2005 3100 3109
73. A.F. Chambers, A.C. Groom, and I.C. MacDonald Dissemination and growth of cancer cells in metastatic sites Nat Rev Cancer 2 2002 563 572